cilostazol has been researched along with casein kinase ii in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, KW; Kim, CD; Kim, KY; Lee, JH; Lee, WS; Rhim, BY; Shin, HK; Shin, YW | 1 |
| Hong, KW; Kim, CD; Kim, KY; Lee, JH; Lee, WS; Lee, YK; Park, SY; Rhim, BY | 1 |
| Chung, WT; Kim, K; Kim, KT; Lee, HJ; Lee, SW; Lee, SY; Park, BS; Park, YC; Shin, SH; Song, YS; Yoo, YH; Yun, I | 1 |
| Hong, KW; Kim, CD; Kim, HY; Lee, HR; Lee, WS; Park, SY; Rhim, BY; Shin, HK | 1 |
4 other study(ies) available for cilostazol and casein kinase ii
| Article | Year |
|---|---|
Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
Topics: Apoptosis; Benzimidazoles; Casein Kinase II; Cell Death; Chromosomes, Human, Pair 10; Cilostazol; Cyclic AMP Response Element-Binding Protein; Humans; Indoles; Microfilament Proteins; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Tensins; Tetrazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins; Vasodilator Agents | 2004 |
Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats.
Topics: Animals; Blood-Brain Barrier; Blotting, Western; Brain Ischemia; Casein Kinase II; Chromosomes; Cilostazol; Cyclic AMP Response Element-Binding Protein; DNA Fragmentation; Infarction; Infarction, Middle Cerebral Artery; Microfilament Proteins; Neuroprotective Agents; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tensins; Tetrazoles; Water | 2004 |
Cilostazol protects rat chondrocytes against nitric oxide-induced apoptosis in vitro and prevents cartilage destruction in a rat model of osteoarthritis.
Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Cartilage, Articular; Casein Kinase II; Caspases; Cells, Cultured; Chondrocytes; Cilostazol; Disease Models, Animal; Dose-Response Relationship, Drug; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoarthritis, Knee; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles; Tumor Suppressor Protein p53 | 2008 |
Protection by cilostazol against amyloid-β(1-40)-induced suppression of viability and neurite elongation through activation of CK2α in HT22 mouse hippocampal cells.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Blotting, Western; Casein Kinase II; Cell Line; Cell Proliferation; Cell Survival; Cilostazol; Enzyme Activation; Gene Knockdown Techniques; Hippocampus; Mice; Neurites; Neuroprotective Agents; RNA, Small Interfering; Signal Transduction; Tetrazoles; Transfection | 2012 |